Donald C. Arbitblit

Partner

San Francisco

Practice Areas Include: Environmental and Toxic Torts, Personal Injury/Torts

Bar Information

Admitted to practice in Vermont, 1979; California and U.S. District Court, Northern District of California, 1986.

Education

Boalt Hall School of Law, University of California (J.D., 1979); Order of the Coif; Tufts University (B.S., magna cum laude, 1974).

Awards

"Northern California Super Lawyer," Law & Politics, 2004, 2006-2008.

Publications

Co-Author with Wendy Fleishman, "The Risky Business of Off-Label Use," Trial (March 2005); “Comment on Joiner: Decision on the Daubert Test of Admissibility of Expert Testimony,” 6 Mealey’s Emerging Toxic Torts, No. 18 (December 1997); Co-author with William Bernstein, “Effective Use of Class Action Procedures in California Toxic Tort Litigation,” 3 Hastings West-Northwest Journal of Environmental Law and Policy, No. 3 (Spring 1996); “The Plight of American Citizens Injured by Transboundary River Pollution,” 8 Ecology Law Quarterly, No. 2 (1979).

Member

Member of the Federal Court-appointed Science Executive Committee, and Chair of the Epidemiology/Clinical Trials Subcommittee, In re Vioxx Products Liability Litigation, MDL No. 1657 (E.D. La.); Federal Science and Expert Witness Committees in In re Diet Drugs (Phentermine/Fenfluramine/ Dexfenfluramine) Products Liability Litigation, MDL No. 1203 (E.D. Pa.), In re Baycol Products Litigation, MDL No. 1431 (D. Minn.) and Rezulin Products Liability Litigation, MDL No. 1348 (S.D.N.Y.); Bar Association of San Francisco; State Bar of California.